Adherex technologies, a biopharmaceutical company focused on development of oncology products, has received SEC approval to be traded on the American Stock Exchange.

Adherex will trade under the symbol ADH effective Friday morning.
The company will continue to trade on the Toronto Stock Exchange as well with the symbol AHX.

“A US listing provides access to a much broader investment base and should better position us for future initiatives, including partnering discussions,” said William Peters, chairman and CEO of Adherex, in a statement.